SAB Biotherapeutics, Inc. Warrant
SABSW
SABSW
10 hedge funds and large institutions have $42.6K invested in SAB Biotherapeutics, Inc. Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
–
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$2K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$9K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$872 |
| 3 |
WAM
3
Wolverine Asset Management
Chicago,
Illinois
|
$688 |
Top Sellers
| 1 |
SCM
1
Shaolin Capital Management
Miami,
Florida
|
$11.2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LP
1
LMR Partners
London,
United Kingdom
| $16.3K | – | – | – |
|
|
SCM
2
Shaolin Capital Management
Miami,
Florida
| $11.2K | -$2.84K | -94,076 | -20% |
|
|
3
Morgan Stanley
New York
| $9K | +$4.5K | +148,939 | +100% |
|
|
YCM
4
Yakira Capital Management
Westport,
Connecticut
| $3.28K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $872 | +$872 | +29,080 | New |
|
6
Walleye Capital
New York
| $702 | – | – | – |
|
|
WAM
7
Wolverine Asset Management
Chicago,
Illinois
| $688 | +$303 | +10,045 | +79% |
|
8
Walleye Trading
New York
| $468 | – | – | – |
|
|
NA
9
NewEdge Advisors
New Orleans,
Louisiana
| $32 | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $1 | – | – | – |
|